← Browse by Condition
Medical Condition
sarcoma
Total Trials
18
Recruiting Now
18
Trial Phases
Phase 2, Phase 1
NCT03449264
Recruiting
Development of Clinical and Biological Database
Enrollment
4,000 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
NCT06272864
Recruiting
BostonGene and Exigent Genomic INsight Study
Enrollment
400 pts
Location
United States
Sponsor
BostonGene
NCT06674811
Recruiting
Biomarkers of Resiliency In Childhood Cancer Surgery
Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
NCT06074692 Phase 2
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Enrollment
86 pts
Location
China
Sponsor
Ruijin Hospital
NCT04300257
Recruiting
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Enrollment
600 pts
Location
Switzerland
Sponsor
Kantonsspital Winterthur KSW
NCT05334069
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i...
NCT04673942 Phase 2
Recruiting
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
Enrollment
140 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT06805669
Recruiting
This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)
Enrollment
136 pts
Location
Canada
Sponsor
Mount Sinai Hospital, Canada
NCT06889766 Phase 1
Recruiting
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Enrollment
9 pts
Location
Switzerland
Sponsor
Centre Hospitalier Universitai...
NCT06103669
Recruiting
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
Enrollment
250 pts
Location
United States
Sponsor
University of California, Davi...
NCT06789172 Phase 1
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Enrollment
166 pts
Location
United States, Austr...
Sponsor
Epkin
NCT06508307 Phase 1
Recruiting
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Enrollment
21 pts
Location
China
Sponsor
GONGCHU Biotechnology Co., Ltd
NCT01772771
Recruiting
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Enrollment
12,000 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT04758325
Recruiting
The Sarcoma Biology and Outcome Project
Enrollment
3,000 pts
Location
Germany
Sponsor
Prof. Dr. Richard F Schlenk
NCT06580002 Phase 2
Recruiting
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Enrollment
51 pts
Location
United States
Sponsor
University of California, Irvi...
NCT05057195
Recruiting
Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy
Enrollment
78 pts
Location
Russia
Sponsor
Blokhin's Russian Cancer Resea...
NCT07432932
Recruiting
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Enrollment
800 pts
Location
United Kingdom
Sponsor
Royal Marsden NHS Foundation T...
NCT05130255 Phase 1
Recruiting
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
Enrollment
60 pts
Location
United States
Sponsor
Y-mAbs Therapeutics